These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36210134)

  • 41. Exercise Intolerance In Heart Failure With Preserved Ejection Fraction.
    Gupte AA; Hamilton DJ
    Methodist Debakey Cardiovasc J; 2016; 12(2):105-9. PubMed ID: 27486493
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Left atrial assist device for heart failure with preserved ejection fraction: initial results with torque control mode in diastolic heart failure model.
    Miyagi C; Kuban BD; Flick CR; Polakowski AR; Miyamoto T; Karimov JH; Starling RC; Fukamachi K
    Heart Fail Rev; 2023 Mar; 28(2):287-296. PubMed ID: 33931816
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Heart Failure with Preserved Ejection Fraction and Future Pharmacological Strategies: a Glance in the Crystal Ball.
    Tschöpe C; Van Linthout S; Kherad B
    Curr Cardiol Rep; 2017 Aug; 19(8):70. PubMed ID: 28656481
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of Interatrial Shunts on Invasive Hemodynamics and Exercise Tolerance in Patients With Heart Failure.
    Griffin JM; Borlaug BA; Komtebedde J; Litwin SE; Shah SJ; Kaye DM; Hoendermis E; Hasenfuß G; Gustafsson F; Wolsk E; Uriel N; Burkhoff D
    J Am Heart Assoc; 2020 Sep; 9(17):e016760. PubMed ID: 32809903
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardiac Contractility Modulation and Baroreflex Activation Therapy in Heart Failure Patients.
    Mann JA; Abraham WT
    Curr Heart Fail Rep; 2019 Feb; 16(1):38-46. PubMed ID: 30762177
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel technologies in the management of heart failure with preserved ejection fraction: a promise during the time of disappointment from pharmacological approaches?
    Nachman D; Asleh R; Amir O
    Curr Opin Cardiol; 2021 Mar; 36(2):211-218. PubMed ID: 33394706
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Left Atrial Decompression Using Unidirectional Left-to-Right Interatrial Shunt: Initial Experience in Treating Symptomatic Heart Failure With Preserved Ejection Fraction With the W-Wave Device.
    Amat-Santos IJ; Del Trigo M; Bergeron S; Pibarot P; Altisent O; Campelo-Parada F; Puri R; Verheye S; Keren G; Katzenellenbogen R; Rozenfeld E; Abraham WT; Bernier M; Rodés-Cabau J
    JACC Cardiovasc Interv; 2015 May; 8(6):870-872. PubMed ID: 25999114
    [No Abstract]   [Full Text] [Related]  

  • 48. Cardiac diastolic and autonomic dysfunction are aggravated by central chemoreflex activation in heart failure with preserved ejection fraction rats.
    Toledo C; Andrade DC; Lucero C; Arce-Alvarez A; Díaz HS; Aliaga V; Schultz HD; Marcus NJ; Manríquez M; Faúndez M; Del Rio R
    J Physiol; 2017 Apr; 595(8):2479-2495. PubMed ID: 28181258
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sudden death in heart failure with preserved ejection fraction and beyond: an elusive target.
    Manolis AS; Manolis AA; Manolis TA; Melita H
    Heart Fail Rev; 2019 Nov; 24(6):847-866. PubMed ID: 31147814
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epidemiology, Diagnosis, Pathophysiology, and Initial Approach to Heart Failure with Preserved Ejection Fraction.
    Anderson T; Hummel SL; Konerman MC
    Cardiol Clin; 2022 Nov; 40(4):397-413. PubMed ID: 36210127
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic importance of pathophysiologic markers in patients with heart failure and preserved ejection fraction.
    Burke MA; Katz DH; Beussink L; Selvaraj S; Gupta DK; Fox J; Chakrabarti S; Sauer AJ; Rich JD; Freed BH; Shah SJ
    Circ Heart Fail; 2014 Mar; 7(2):288-99. PubMed ID: 24365774
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiac Power Output Is Independently and Incrementally Associated With Adverse Outcomes in Heart Failure With Preserved Ejection Fraction.
    Harada T; Yamaguchi M; Omote K; Iwano H; Mizuguchi Y; Amanai S; Yoshida K; Kato T; Kurosawa K; Nagai T; Negishi K; Anzai T; Obokata M
    Circ Cardiovasc Imaging; 2022 Feb; 15(2):e013495. PubMed ID: 35144484
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Integration of exercise evaluation into the algorithm for evaluation of patients with suspected heart failure with preserved ejection fraction.
    van Empel VP; Kaye DM
    Int J Cardiol; 2013 Sep; 168(2):716-22. PubMed ID: 23711448
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Do we need a definition of acute heart failure with preserved ejection fraction?
    Kapłon-Cieślicka A; Lund LH
    Ann Med; 2021 Dec; 53(1):1470-1475. PubMed ID: 34431429
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chronic baroreflex activation: a potential therapeutic approach to heart failure with preserved ejection fraction.
    Georgakopoulos D; Little WC; Abraham WT; Weaver FA; Zile MR
    J Card Fail; 2011 Feb; 17(2):167-78. PubMed ID: 21300307
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment of Predictors of Left Atrial Volume Response to a Transcatheter InterAtrial Shunt Device (from the REDUCE LAP-HF Trial).
    Hanff TC; Kaye DM; Hayward CS; Post MC; Malek F; Hasenfuβ G; Gustafsson F; Burkhoff D; Shah SJ; Litwin SE; Kahwash R; Hummel SL; Borlaug BA; Solomon SD; Lam CSP; Komtebedde J; Silvestry FE;
    Am J Cardiol; 2019 Dec; 124(12):1912-1917. PubMed ID: 31653352
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanisms of atrial fibrillation in aged rats with heart failure with preserved ejection fraction.
    Mesquita TRR; Zhang R; de Couto G; Valle J; Sanchez L; Rogers RG; Holm K; Liu W; Marbán E; Cingolani E
    Heart Rhythm; 2020 Jun; 17(6):1025-1033. PubMed ID: 32068183
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Device therapy: Interatrial shunt device for HFpEF.
    Lim GB
    Nat Rev Cardiol; 2018 Jan; 15(1):4. PubMed ID: 29188804
    [No Abstract]   [Full Text] [Related]  

  • 59. Low-level transcutaneous vagus nerve stimulation attenuates cardiac remodelling in a rat model of heart failure with preserved ejection fraction.
    Zhou L; Filiberti A; Humphrey MB; Fleming CD; Scherlag BJ; Po SS; Stavrakis S
    Exp Physiol; 2019 Jan; 104(1):28-38. PubMed ID: 30398289
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Right ventricular dysfunction in left-sided heart failure with preserved versus reduced ejection fraction.
    Bosch L; Lam CSP; Gong L; Chan SP; Sim D; Yeo D; Jaufeerally F; Leong KTG; Ong HY; Ng TP; Richards AM; Arslan F; Ling LH
    Eur J Heart Fail; 2017 Dec; 19(12):1664-1671. PubMed ID: 28597497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.